Charles River Laboratories (CRL) — Cash Flow-to-Debt Ratio
Charles River Laboratories (CRL) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of $213.83 Million could theoretically repay 0% of its total liabilities ($4.06 Billion) in one year. See CRL cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Charles River Laboratories Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for Charles River Laboratories across 27 annual periods. Also explore Charles River Laboratories annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Charles River Laboratories (1998–2024)
Year-by-year debt coverage analysis for Charles River Laboratories. For market capitalisation and broader financial context, see CRL company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.18x | $734.58 Million | $4.02 Billion | ▲ +21.2% |
| 2023 | 0.15x | $683.90 Million | $4.54 Billion | ▲ +11.4% |
| 2022 | 0.14x | $619.64 Million | $4.58 Billion | ▼ -21.2% |
| 2021 | 0.17x | $760.80 Million | $4.43 Billion | ▲ +5.1% |
| 2020 | 0.16x | $546.58 Million | $3.35 Billion | ▲ +2.8% |
| 2019 | 0.16x | $480.94 Million | $3.03 Billion | ▼ -9.3% |
| 2018 | 0.18x | $441.14 Million | $2.52 Billion | ▲ +3.4% |
| 2017 | 0.17x | $316.26 Million | $1.87 Billion | ▲ +5.6% |
| 2016 | 0.16x | $298.32 Million | $1.86 Billion | ▼ -26.9% |
| 2015 | 0.22x | $286.36 Million | $1.30 Billion | ▲ +3.4% |
| 2014 | 0.21x | $251.05 Million | $1.18 Billion | ▲ +0.6% |
| 2013 | 0.21x | $207.14 Million | $979.96 Million | ▼ 0.0% |
| 2012 | 0.21x | $207.90 Million | $983.14 Million | ▲ +6.0% |
| 2011 | 0.20x | $205.28 Million | $1.03 Billion | ▲ +23.3% |
| 2010 | 0.16x | $169.01 Million | $1.04 Billion | ▼ -40.3% |
| 2009 | 0.27x | $225.04 Million | $830.27 Million | ▼ -7.0% |
| 2008 | 0.29x | $279.95 Million | $960.47 Million | ▼ -3.5% |
| 2007 | 0.30x | $284.25 Million | $941.57 Million | ▲ +75.1% |
| 2006 | 0.17x | $164.37 Million | $953.11 Million | ▼ -48.9% |
| 2005 | 0.34x | $236.70 Million | $701.48 Million | ▲ +109.0% |
| 2004 | 0.16x | $184.83 Million | $1.14 Billion | ▼ -57.6% |
| 2003 | 0.38x | $123.77 Million | $324.75 Million | ▼ -7.2% |
| 2002 | 0.41x | $133.66 Million | $325.40 Million | ▲ +54.9% |
| 2001 | 0.27x | $71.30 Million | $268.86 Million | ▲ +120.2% |
| 2000 | 0.12x | $33.77 Million | $280.35 Million | ▲ +51.6% |
| 1999 | 0.08x | $37.57 Million | $472.89 Million | ▼ -86.0% |
| 1998 | 0.57x | $37.38 Million | $65.69 Million | — |